References

1. Hamilton MG, Hull RD, Pineo GF. (1994). Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 34: 280-296.

2. Geerts WH et al. (2004). Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl.): 338S-400S (Review).

3. Chan AT et al. (1999). Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis 8: 139-142.

4. Koh MB, Hunt BJ. (2003). The management of perioperative bleeding. Blood, Rev 17(3): 179-185.

5. Powner DJ, Hartwell EA, Hoots WK. (2005). Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 57(5): 823-831.

6. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. (2004). Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl.): 287S-310S.

7. Baglin TP, Keeling DM, Watson HG, British Committee for Standards in Haema-tology. (2006). Guidelines on oral anticoagulation (warfarin): third edition 2005 update. BrJ Haematol 132(3): 277-285.

8. Weitz JI, Hirsh J, Samama MM. (2004). New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl.): 265S-286S (Review).

9. Park P, Fewel ME, Garton HJ, Thompson BG, HoffJT. (2003). Recombinant activated factor VII for the rapid correction of coagulopathy in non-hemophilic neurosurgical patients. Neurosurgery 53(1): 34-38.

10. Lee CA, Berntorp EE, Hoots WK (eds.) (2005). Textbook of Haemophilia. Blackwell Publishing Ltd.

11. Doughty HA, Coles J, Parmar K, Bullock P, Savidge GF. (1995). The successful removal of a bleeding intracranial tumour in a severe haemophiliac using an adjusted dose continuous infusion of monoclonal factor VIII. Blood Coagul Fibrinolysis 6: 31-34.

12. van Doormaal TPC, Tulleken CAF. (2006). Treatment of giant and large internal carotid artery aneurysms with a high flow replacement bypass using excimer laser assisted non-occlusive anastomosis technique. Neurosurgery 59(ONS 5): 328-335.

13. Malis L. (2006). Electrosurgery and bipolar technology. Neurosurgery 58(ONS 1): ONS-1-ONS-12.

14. Rhoton ALJr. (1993). Instrumentation. In: Apuzzo MLJ (eds.), Brain Surgery: Complication Avoidance and Management (New York, Vol. 2, pp. 1647-1670).

15. Ellegala DB, Maartens NF, Laws ER. (2002). Use of FloSeal matrix haemostatic sealant in transsphenoidal pituitary surgery. Neurosurgery 51(2): 513-516.

16. Collins WF. (1993). Problematic intraoperative events. In: Apuzzo MLJ (ed.), Brain Surgery: Complication Avoidance and Management (New York, Vol. 1, pp. 93-96).

17. Palmer JD, Francis JL, Pickard JD, Iannotti F. (2003). The efficacy and safety of aprotinin for hemostasis during intracranial surgery. J Neurosurg 98(6): 1208-1216.

18. Epstein NE. (2005). A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 64(4): 295-301 (discussion 302; Review).

19. Becattini C, Agnelli G, Emmerich J, Bura A, WeitzJI. (2006). Initial treatment of venous thromboembolism. Thromb Haemost 96(3): 242-250.

20. Gerber DE, Grossman SA, Streiff MB. (2006). Management of venous thromboembolism in patients with primary and metastatic brain tumours. J Clin Oncol 24(8): 1310-1318.

21. Baglin TP, Brush J, Streiff M, British Committee for Standards in Haematology. (2006). Guidelines on use of vena cava filters. BrJHaematol 134(6): 590-595.

This page intentionally left blank

CHAPTER

Was this article helpful?

0 0

Post a comment